The role of cannabis in pain management among people living with HIV who use drugs: A qualitative study Koharu Loulou Chayama, Jenna Valleriani, Cara Ng, Rebecca Haines-Saah, Rielle Capler, M.-J. Milloy, Will Small, Ryan McNeil Introduction People living with HIV who use drugs commonly experience chronic pain and often use illicit opioids to manage pain. […]
Read More
Medical cannabis in the UK: From principle to practice Anne Katrin Schlag, David S Baldwin, Michael Barnes, Steve Bazire, Rachel Coathup, H Valerie Curran, Rupert McShane, Lawrence D Phillips, Ilina Singh, David J Nutt Background: In the UK, medical cannabis was approved in November 2018, leading many patients to believe that the medicine would […]
Read More
Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample Sinikka L. Kvamme, Michael M. Pedersen, Kristine Rømer Thomsen & Birgitte Thylstrup Background The use of cannabis as medicine (CaM) both prescribed and non-prescribed has increased markedly in the last decade, mirrored in a global shift in cannabis policy […]
Read More
Proportion of Prescribed Conditions & Latest Patient Approval Numbers To date, the TGA has approved SAS applications including, but not limited to, the following indications: chemotherapy-induced nausea and vomiting refractory paediatric epilepsy palliative care indications cancer pain neuropathic pain spasticity from neurological conditions anorexia and wasting associated with chronic illness (such as cancer) A break […]
Read More